-
First European Patent Claims Now Allowed For Microwave Peptide Synthesis
8/26/2010
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office. The allowed application contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synthesis, deprotection and coupling. It also covers the process of performing Fmoc and
-
Enzo Biochem’s Clinical Lab Takes Major Step In Becoming National Provider Of Predictive Diagnostics
8/26/2010
In the first of several moves to expand the Company's position as a national provider of esoteric and high value diagnostics, Enzo Biochem, Inc. announced recently that its Enzo Clinical Labs division has been awarded a license for doing business in the Commonwealth of Pennsylvania, the first of several for which it has applied
-
Stanford University Deploys SGI Solutions To Accelerate Research On Solar Variability
8/25/2010
SGI, a global leader in HPC and data center solutions, recently announced that the Hansen Experimental Physics Laboratory Solar Observatories Group at Stanford University has selected SGI server and storage infrastructure to support the Solar Dynamic Observatory (SDO) group's critical research on the origin of solar variability
-
Alnylam And Collaborators Publish New Pre-Clinical Research On Therapeutic Silencing Of Parkinson’s Disease Gene
8/23/2010
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS).
-
Angeion And Data Innovations Partner To Create New MedGraphics BreezeConnect
8/20/2010
Angeion Corporation recently announced that it has partnered with Data Innovations to create MedGraphics BreezeConnect, a software interface that provides interfacing options in one comprehensive solution. BreezeConnect is currently available in the United States and is expected to launch internationally in September
-
IMGM Laboratories GmbH And The Center For Human Genetics And Laboratory Medicine To Develop Workflows For Use Of 454 Sequencing Systems In Human Genetics
8/19/2010
The two German-based sister companies, IMGM Laboratories GmbH and the Center for Human Genetics and Laboratory Medicine Dr. Klein and Dr. Rost, have announced their plans to use the GS FLX System and GS Junior System from 454 Life Sciences, a Roche company, for the joint development of robust and efficient workflows for targeted resequencing applications in the field of human genetics
-
Intertek Expands Michigan Facility; Adds EMC (Electromagnetic Compatibility) Testing Lab For MIL/Aerospace, Auto, Medical And Consumer Products
8/18/2010
Intertek, a global leader in testing, inspection and certification, announced recently that it is adding four (4) Electromagnetic Compatibility (EMC) test chambers to its Grand Rapids, MI commercial testing facility to perform electrical interference and immunity evaluations to aerospace, automotive, consumer product, medical and military requirements
-
Thermo Fisher Scientific Expands Presence In China With New Technology Center In Shanghai
8/18/2010
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has opened a Technology Center in Shanghai, building on its engineering and development capabilities to meet the specific needs of customers in China
-
MidSouth eHealth Alliance Signs Contract For HIE Continuance With Informatics Corporation Of America (ICA)
8/17/2010
Informatics Corporation of America announced recently that the Memphis-based MidSouth eHealth Alliance (MSeHA) has signed a multi-year contract with ICA to provide its commercial CareAlign solution for continued HIE capabilities. In 2004, MSeHA was initially awarded an Agency for Healthcare Research and Quality (AHRQ) grant in collaboration with the Vanderbilt Medical Center's Regional Informatics team to develop data sharing capability within the Memphis community, with the primary goal of assisting with
-
Advaxis Signs Veterinary Study Contract With The University Of Pennsylvania School Of Veterinary Medicine
8/17/2010
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company and the University of Pennsylvania School of Veterinary Medicine have signed a veterinary clinical research study contract to treat osteosarcoma in companion dogs using Advaxis' technology. The studies will be led by Assistant Professor Dr. Nicola Mason